NeoGenomics, Inc. (NEO) earnings
NEO earnings moved a median of -0.57% by the close. Quarterly and annual NEO reports and results, each read against the price at its own news timestamp. Back to the NEO overview →
31 measured NEO earnings events.
Where these NEO earnings landedvs 28 measured NEO earnings reactions
| Middle 50% of NEO earnings reactions | -4.61% to +2.10% |
|---|---|
| Median reaction (to close) | -0.57% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 NEO earnings events with a measured close landed between -4.61% and +2.10%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026 | Press release | — | — | |
| Form 10-Q NEOGENOMICS INC For: Jun 30 | SEC filing · Form 10-Q | -0.55% | -1.48% | |
| NeoGenomics Reports Second Quarter 2026 Results | Press release | -0.55% | -1.48% | |
| NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026 | Press release | +0.56% | -3.91% | |
| Form 10-Q NEOGENOMICS INC For: Mar 31 | SEC filing · Form 10-Q | -4.59% | -12.41% | |
| NeoGenomics Reports First Quarter 2026 Results | Press release | -4.59% | -12.41% | |
| NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026 | Press release | +0.25% | +0.37% | |
| Form 10-K NEOGENOMICS INC For: Dec 31 | SEC filing · Form 10-K | -3.81% | -10.08% | |
| Form 10-Q NEOGENOMICS INC For: Sep 30 | SEC filing · Form 10-Q | +2.47% | +1.68% | |
| NeoGenomics Reports Third Quarter 2025 Results | Press release | -0.42% | -8.32% | |
| NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 | Press release | -1.19% | -2.27% | |
| Form 10-Q NEOGENOMICS INC For: Jun 30 | SEC filing · Form 10-Q | -2.08% | — | |
| NeoGenomics Reports Second Quarter 2025 Results | Press release | -2.08% | — | |
| NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025 | Press release | +0.14% | +2.07% | |
| Form 10-Q NEOGENOMICS INC For: Mar 31 | SEC filing · Form 10-Q | -1.86% | -0.85% | |
| NeoGenomics Reports First Quarter 2025 Results | Press release | -8.04% | -31.74% | |
| NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025 | Press release | -0.82% | -10.28% | |
| Form 10-K NEOGENOMICS INC For: Dec 31 | SEC filing · Form 10-K | -3.11% | +4.18% | |
| Form 10-Q NEOGENOMICS INC For: Sep 30 | SEC filing · Form 10-Q | -1.85% | -1.40% | |
| NeoGenomics Reports Third Quarter 2024 Results | Press release | +1.25% | +10.19% | |
| NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024 | Press release | +0.51% | +1.81% | |
| Form 10-Q NEOGENOMICS INC For: Jun 30 | SEC filing · Form 10-Q | -1.26% | +1.31% | |
| NeoGenomics Reports Second Quarter 2024 Results | Press release | +5.54% | +8.69% | |
| NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024 | Press release | +0.29% | -1.18% | |
| Form 10-Q NEOGENOMICS INC For: Mar 31 | SEC filing · Form 10-Q | +1.82% | -0.29% | |
| NeoGenomics Reports First Quarter 2024 Results | Press release | -6.17% | -6.70% | |
| NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024 | Press release | +0.84% | +2.22% | |
| Form 10-K NEOGENOMICS INC For: Dec 31 | SEC filing · Form 10-K | -4.21% | +0.49% | |
| Form 10-Q NEOGENOMICS INC For: Sep 30 | SEC filing · Form 10-Q | -2.06% | +4.56% | |
| NeoGenomics Reports Third Quarter 2023 Results | Press release | -2.06% | +4.56% | |
| NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023 | Press release | +1.28% | +10.07% |
Keep exploring
More NEO: analyst actions → · SEC filings → · NEO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Align Technology, Inc. (ALGN) | 407 | -0.00% | 50% |
| ALLIQUA BIOMEDICAL (ALQA) | 407 | -0.11% | 43% |
| Vericel Corporation (VCEL) | 406 | -0.19% | 40% |
| SPRING BANK PHARMACEUTICALS (SBPH) | 404 | 0.00% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.